PRA HEALTH SCIENCES INC's ticker is PRAH and the CUSIP is 69354M108. A total of 282 filers reported holding PRA HEALTH SCIENCES INC in Q4 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,861,000 | -81.2% | 38,940 | -79.1% | 0.43% | -75.0% |
| Q1 2019 | $20,518,000 | +17.0% | 186,040 | -2.4% | 1.72% | +7.4% |
| Q4 2018 | $17,535,000 | -33.1% | 190,680 | -19.8% | 1.60% | -6.3% |
| Q3 2018 | $26,212,000 | +17.6% | 237,880 | -0.3% | 1.71% | +8.0% |
| Q2 2018 | $22,283,000 | -2.0% | 238,680 | -12.9% | 1.58% | +10.6% |
| Q1 2018 | $22,738,000 | -11.6% | 274,080 | -2.9% | 1.43% | -2.9% |
| Q4 2017 | $25,716,000 | +18.8% | 282,380 | -0.6% | 1.47% | +10.8% |
| Q3 2017 | $21,646,000 | -1.6% | 284,180 | -3.1% | 1.33% | -1.8% |
| Q2 2017 | $21,991,000 | +119.2% | 293,180 | +90.6% | 1.35% | +116.8% |
| Q1 2017 | $10,031,000 | +57.9% | 153,780 | +33.4% | 0.62% | +48.9% |
| Q4 2016 | $6,354,000 | +1843.1% | 115,280 | +1894.5% | 0.42% | +1895.2% |
| Q3 2016 | $327,000 | +35.7% | 5,780 | 0.0% | 0.02% | +31.2% |
| Q2 2016 | $241,000 | -2.4% | 5,780 | 0.0% | 0.02% | -5.9% |
| Q1 2016 | $247,000 | -5.7% | 5,780 | 0.0% | 0.02% | -19.0% |
| Q4 2015 | $262,000 | – | 5,780 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kerrisdale Advisers, LLC | 112,000 | $12,449,000 | 4.40% |
| South Street Advisors LLC | 113,951 | $12,666,000 | 3.28% |
| Tavio Capital LLC | 78,141 | $8,685,000 | 3.20% |
| Ranger Investment Management | 422,097 | $46,916,000 | 3.09% |
| Bellecapital International Ltd. | 49,878 | $5,544,000 | 2.84% |
| Tygh Capital Management, Inc. | 148,822 | $16,542,000 | 2.73% |
| Sloane Robinson LLP | 62,700 | $6,969,000 | 2.69% |
| Endurant Capital Management LP | 58,983 | $6,556,000 | 2.06% |
| REILLY FINANCIAL ADVISORS, LLC | 111,561 | $12,400,000 | 1.41% |
| Pendal Group Ltd | 963,310 | $107,071,907,000 | 1.40% |